NCT04276701View on ClinicalTrials.gov

Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

blood sample

35 ml whole blood for Peripheral blood mononuclear cell (PBMC), serum and plasma

OTHER

Ultrasonography assessment

assessment of atherosclerotic plaques and measurement of carotid intima-media thickness (cIMT)

BEHAVIORAL

questionnaires

Food and exercise questionnaires validated by the American heart Association

Trial Locations (6)

Unknown

RECRUITING

CHU de Bordeaux - service de médecine interne, Bordeaux

RECRUITING

CHU de Brest - service de rhumatologie, Brest

RECRUITING

CHRU de Lille - service de Médecine Interne, Lille

NOT_YET_RECRUITING

AP-HP - Hôpital Cochin - service de Médecine Interne, Paris

RECRUITING

CHU de Strasbourg - service d'Immunologie Clinique, Strasbourg

NOT_YET_RECRUITING

Universität Freiburg, Freiburg im Breisgau

All Listed Sponsors
collaborator

Foundation for Research in Rheumatology (FOREUM)

UNKNOWN

lead

University Hospital, Bordeaux

OTHER